Absolute Pro LL. Peripheral Self-Expanding Stent System. Delivering Absolute Performance Extending Our Legacy FPO .035

Similar documents
When Outcomes Matter, Design Matters

Clinically proven. ordering info. Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW. Pulsar-18

PERFORMANCE YOU CAN TRUST. EverFlex Self-expanding Peripheral Stent with Entrust Delivery System

NIRxcell CoCr Coronary Stent System

Mechanical Properties of the GORE TIGRIS Vascular Stent

MEET M. Bosiers K. Deloose P. Peeters. SFA stenting in 2009 : The good and the ugly What factors influence patency?

Finally, the Control You Need to Deliver Accurate Treatment

Chronic Total Occlusion (CTO) Technologies

Or is the ivolution stent a better alternative? EVOLUTION 12-month data

Update in femoral angioplasty & stenting PRO

5F Devices with 0.035

Expanding to every demand: The GORE VIABAHN VBX Stent Graft

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide

LOWERING THE PROFILE RAISING THE BAR

Talent Abdominal Stent Graft

Chronic Total Occlusion (CTO) Technologies. Re-open vital channels

Minimizing Burden, the effect of thin strut and low Chronic Outward Force SE stents

All-In-One. Iliac Branch System. PER F ORM ANC E b y d e s i g n ILIAC BRANCH ENDOPROSTHESIS

Update on the Levant 2 Clinical Trial Programme. Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany

THE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT

Proven Performance Through Innovative Design *

FROM THE EVERYDAY TO THE EXTRAORDINARY

SFA lesion treatment: China experience. Wei Liang, MD

Sustained Release. Superior Results.

The Final Triumph Of Endovascular Therapy In SFA Treatment

INTRODUCING. Cordis POWERFLEX Pro PTA Dilatation Catheter

EluNIR. Ridaforolimus Eluting Coronary Stent System. Advancing Deliverability for the Road Ahead

Shaping the future with the swirling flow stent

A Data-driven Therapeutic Algorithm For Choosing Among Currently Available Tools For SFA Intervention

Durable outcomes. Proven performance.

Right Choice for Right Angles

INTERVENTIONAL VASCULAR DIAGNOSTICS AND THERAPY. VascuFlex Peripheral Stent Systems. Self-Expanding Peripheral Nitinol Stents

Advanced Innovation for Exceptional Performance

Is a Stent or Scaffold Necessary in The SFA?

CHALLENGES IN FEMORO-POPLITEAL STENTING

The evolution. AORFIX AAA Stent Graft now with the new AORFLEX Delivery System

A New EVAR Device for Infrarenal AAAs

NC EMERGE TM PTCA Dilatation Catheter

ABDOMINAL XT ABDOMINAL STENT GRAFT SYSTEM

Expect Slimline (SL) Endoscopic Ultrasound Aspiration Needle EXPANDED INDICATIONS AVAILABLE IN THE U.S. WITH

Disclosures. In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA

Recent Advances in Peripheral Salvage

Could a combination of DCB + stent be the answer in complex SFA lesions

Does stent design influence the results of SFA stenting?

JETSTREAM Atherectomy System DELIVERING VERSATILITY TO RESTORE FLOW

Complex ilio-caval revascularization in chronic venous obstruction with the Venovo Stent. Michael K. W. Lichtenberg MD, FESC

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA

XIENCE Sierra INTRODUCING

Roadsaver the paradigm shift in carotid artery treatment. G. Torsello Münster

My personal experience with INCRAFT in standard and challenging cases

MAXIMIZE RADIAL SOLUTIONS TO PERIPHERAL CHALLENGES

On behalf of the DURABILITY Investigators:

thoracic stent graft system Smallest delivery profile as from 20 F

Indications for use. Contraindications within the United States

Vascular V12. Covered Stent. The New Standard of Care

Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM

TurboHawk. Plaque Excision System

Access More Patients. Customize Each Seal.

SEE WHY ZILVER PTX IS A GAME CHANGER.

SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

CLOSES WITH SECURITY. LEAVES WITHOUT A TRACE.

Zenith Renu AAA Converter Graft. Device Description Planning and Sizing Deployment Sequence Patient Follow-Up

Clinical benefits on DES Patient s perspectives

The Art of. Flow Restoration. Ikazuchi Zero. Semi-Compliant PTCA Balloon OVERVIEW CROSSABILITY LOW PROFILE CASE STUDY CODES

Evaluating the economic value of 5F systems for outpatients

Appropriate Device Selection for Endovascular Procedures

Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit?

ENDOVASCULAR FEMORAL STENTS CAN WE RELY ON LONG-TERM FRIENDSHIP?

Treatment Strategies for Long Lesions of greater than 20 cm

4/14/2016. Faculty Disclosure. Drug-eluting technology in the SFA and Popliteal. Typical SFA Disease Pattern. Why Peripheral Artery Disease Matters

Straub Endovascular System &

Durability of The Endurant Stent-Graft through 5 Years

Pulsar stent technology

Superficial Femoral Artery Intervention: The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA

Ovation. Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic

DURABLE. CONSISTENT. SAFE. IN.PACT Admiral Drug-Coated Balloon

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu

Yukon Choice PC Translumina trust is what counts

Ruby Coil. Large Volume Detachable Coils

The Challenge of Accurately Stenting Aorto-Ostial Lesions

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD

A Dedicated Venous Self-expanding Oblique Hybrid Nitinol Stent (Sinus-Obliquus Stent)

Resolute Integrity. Independent Conformability Assessment

Long-term results with interwoven nitinol stents vs. BMS vs. DCB

System.

Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography

Maximize Control. Minimize Migration.

PressureWire Aeris with Agile Tip Technology. Wireless FFR Functionality and Handles like a Workhorse PCI Guidewire 1

New Fully Absorbable Patch Based Large Hole Vascular Closure Device

Filtek. Bulk Fill. Posterior Restorative. One. and done.

Challenging anatomies demand versatility.

Root ZX mini Proven Accuracy in a New Compact Design. Thinking ahead. Focused on life.

Maximizing Outcomes in a complex population with Drug-coated balloon

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL

- Saturday, February 03, :56:12 PM - IP Address:

Cordis ExoSeal. Maximise Clinical Safety*. The novel approach to secure and easy closure. Vascular Closure Device CORDIS EXOSEAL VCD

FLEXIBLE, BALOON EXPANDABLE

A CATHETER FAMILY FOR ALL YOUR PATIENT NEEDS

Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment

CAROTID ARTERY ANGIOPLASTY

Transcription:

Pro LL Peripheral Self-Expanding Stent System Clinically proven to treat long SFA lesions Superb durability 1- Delivering Performance Extending Our Legacy Uncompromised deliverability FPO.03 Endovascular Coitment Six Degrees does not recoend this

Pro LL Peripheral Self-Expanding Stent System Clinically Proven to Treat Long SFA Lesions 1-3 Lower binary restenosis rate and sustained clinical benefit with stent compared with Quality of life significantly improved after stenting compared to Superb Durability Excellent stent fracture resistance 1-4 Stent Design Resistance Surface Finish Stent Material - Stent material and stent design for outstanding flexibility and vessel conformability - Advanced stent electro and micro polish for optimal surface finish to enhance stent durability Uncompromised Deliverability Triaxial Technology Triaxial technology with: - Stabilizing sheath to absorb stored energy and minimize friction during deployment - I-Beam laser-cut hypotube for longitudinal strength, flexibility and pushability during stent delivery Ergonomic handle for easy one-handed, controlled deployment

Delivering Performance Triaxial Technology Stabilizing Sheath for deployment accuracy I-Beam for kink resistance and uncompromised deliverability Outer Member for ease of deployment Thumb Wheel for easy one-handed, controlled stent deployment

Extending Our Legacy Now available in 1 and lengths* 1 * Artwork shown not to scale. Stent optimal surface for enhanced stent durability Low Tip Profile for crossing tight lesions

Delivering Performance Binary Restenosis stent shows sustained benefit when compared to % % % % 1-12 24 p=0.3 p=0.0 p=0.01 p=0.031 3 12 24 p=0.3 p=0.0 p=0.01 p=0.031 3 12 p=0.3 p=0.0 % % 1-3 Lowest fracture rate across trials 3 4.3% 13.% 4.% 3.%.2% 3.% 22.% 2.% +/-22.% Stent 13.% 24.2% p=0.031 p=0.013.% 4.3% 2.% +/Stent 4.3% 3.% 3.% 4.%.2% 4.% 3.% 22.% 2.% 13.% Stent Rate (per limb) DURABILITY I Study Follow-up 24 Follow-up 24 % DURABILITY 12 I Study DURABILITY I 12Study 1 43 32 1 Registry 43 Registry 32 SIROCCO 24 II SIROCCO II 24 12 1 322.% 242.2% % Follow-up % % % % % % Lesion length % 24 1.% Registry 43 1.2% 1.%.1% 1 1.% Protégé EverFlex.4 Lesion length Lesion length 1.2% 2.% 2.2% 2.% 13.3 2.2%.1% 12 1.% Wallstent 1.% 1 Protégé EverFlex.1%.4 1.% 12 Wallstent 13.3 1 Protégé EverFlex.4 12 Wallstent 13.3 1.2% 00 0 00 0 0 0 (gf) 0 0 (gf) 24 Pro LL 42 42 42 42 42 42 1 2 3 4 44 44 44 LifeStent FlexStar XL Complete SE 24 Pro LL 24 LifeStent FlexStar XL Complete SE (gf) Pro LL LifeStent FlexStar XL Complete SE Data on file at Abbott Vascular. M. Schillinger et al. / NEJM; Vol 34, N1: 1-1 / M. Schillinger / Circulation 0; 11:24-24 S. Sabeti / J Endovasc Ther 0; 14:431-43 O. Schlager et al / J Endovasc Ther 0; 12:-4 S.H. Duda et al. J Endovasc Ther 0;13:01- Marc Bosiers et al. J Endovasc Ther 0; 1:21-2 SIROCCO II 00 Flexibility of Sheathed Stent on Delivery System Best-in-class flexibility during stent delivery

Pro LL Ordering Information LENGTH 0 (cm) 1 1 1 1-1 - -1-1-1 1-111-1 111- Pro STOCK NUMBER CATHETER LENGTH 13 (cm) REFERENCE VESSEL SHEATH GUIDING CATHETER 3.-4. 3.-4. 4.3-.4 4.3-.4.0-.3.0-.3.-.3.-.3 REFERENCE VESSEL SHEATH GUIDING CATHETER 3.-4. 3.-4. 3.-4. 3.-4. 3.-4. 3.-4. 4.3-.4 4.3-.4 4.3-.4 4.3-.4 4.3-.4 4.3-.4.0-.3.0-.3.0-.3.0-.3.0-.3.0-.3.-.3.-.3.-.3.-.3.-.3.-.3.4-.2.4-.2.4-.2.4-.2.4-.2.4-.2.1-.1.1-.1.1-.1.1-.1.1-.1.1-.1 114-1 114-11-1 11-11-1 11-11-1 11- Ordering Information LENGTH 0 (cm) STOCK NUMBER CATHETER LENGTH 0 0 0 0 0 0 0 0 0 0 0 0 1114-0 1114-0 1114-0 1114-00 1114-00 1114-111-0 111-0 111-0 111-00 111-00 111-111-0 111-0 111-0 111-00 111-00 111-111-0 111-0 111-0 111-00 111-00 111-111-0 111-0 111-0 111-00 111-00 111-111-0 111-0 111-0 111-00 111-00 111-13 (cm) 11-0 11-0 11-0 11-00 11-00 11-1121-0 1121-0 1121-0 1121-00 1121-00 1121-1122-0 1122-0 1122-0 1122-00 1122-00 1122-1123-0 1123-0 1123-0 1123-00 1123-00 1123-1124-0 1124-0 1124-0 1124-00 1124-00 1124-112-0 112-0 112-0 112-00 112-00 112- Please contact your local representative for more information. Abbott Vascular Australia Abbot Vascular New Zealand Level, 1 Talavera Road North Ryde NSW 2113 Tel: 0 3 Tel: +1 2 0 Fax: +1 2 Level 3, Kingdon Street New Market Auckland Tel: 000 2 2 Tel: +4 24 0 Fax: +4 24 4 All illustrations included are artist s renditions. All tests performed by and data on file at Abbott Vascular. Pro is a trademark of Abbott Laboratories. self-expanding stent system is a trademark of Cordis, a J&J Company. LifeStent FlexStar XL Vascular Stent System is a trademark of C. R. Bard, Inc. Wallstent Endoprosthesis is a registered trademark of Boston Scientific Corp. Protégé EverFlex Self-Expanding Peripheral Stent System is a trademark of ev3 Inc. Complete SE Iliac is a trademark of Medtronic, Inc. This product is intended for use by or under the direction of a physician. Prior to use, it is important to read the package insert thoroughly for Instructions for Use, warnings and potential complications associated with use of this device. Information contained herein for distribution in Australia and New Zealand only. For more information, visit our web site at abbottvascular.com 0 Abbott Laboratories. All rights reserved. ANZ 0011 03/12.